Technical Analysis for CORT - Corcept Therapeutics Incorporated

Grade Last Price % Change Price Change
D 28.09 2.00% 0.55
CORT closed up 2.0 percent on Friday, May 17, 2024, on 77 percent of normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
New Uptrend Bullish 0.00%
Wide Bands Range Expansion 0.00%
NR7 Range Contraction 2.00%
NR7-2 Range Contraction 2.00%
Narrow Range Bar Range Contraction 2.00%
Upper Bollinger Band Walk Strength 2.00%
Wide Bands Range Expansion 2.00%
NR7 Range Contraction 0.93%
Upper Bollinger Band Walk Strength 0.93%
Wide Bands Range Expansion 0.93%

   Recent Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Corcept Therapeutics Incorporated Description

Corcept Therapeutics Incorporated, a pharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of severe metabolic and psychiatric disorders in the United States. The company focuses on disorders that are associated with a steroid hormone called cortisol. It offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. The company is also involved in an on-going Phase III study of mifepristone, the active ingredient in Korlym, for treatment of the psychotic features of psychotic depression. In addition, it discovers and develops three series of novel selective GR-II antagonists. The company has research and development agreements with Argenta Discovery Limited; Sygnature Discovery Limited; ICON Clinical Research, L.P.; and MedAvante, Inc. as well as has a patent license from Stanford University for developing mifepristone. Corcept Therapeutics Incorporated was founded in 1998 and is headquartered in Menlo Park, California.


Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Organ Systems Diabetes Surgery Disorders Clinical Research Glucose Endocrine System Depression Hormones Diabetes Mellitus Psychiatric Disorders Hyperglycemia Antiprogestogens Cushing's Syndrome

Is CORT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 34.275
52 Week Low 20.84
Average Volume 1,063,126
200-Day Moving Average 26.69
50-Day Moving Average 24.54
20-Day Moving Average 24.95
10-Day Moving Average 26.61
Average True Range 1.21
RSI (14) 70.67
ADX 25.17
+DI 34.20
-DI 13.59
Chandelier Exit (Long, 3 ATRs) 25.65
Chandelier Exit (Short, 3 ATRs) 24.46
Upper Bollinger Bands 29.03
Lower Bollinger Band 20.88
Percent B (%b) 0.89
BandWidth 32.63
MACD Line 1.09
MACD Signal Line 0.69
MACD Histogram 0.4035
Fundamentals Value
Market Cap 2.9 Billion
Num Shares 103 Million
EPS 0.80
Price-to-Earnings (P/E) Ratio 35.11
Price-to-Sales 5.27
Price-to-Book 5.14
PEG Ratio 0.61
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 29.29
Resistance 3 (R3) 29.24 28.78 29.09
Resistance 2 (R2) 28.78 28.48 28.81 29.02
Resistance 1 (R1) 28.44 28.29 28.61 28.49 28.96
Pivot Point 27.98 27.98 28.07 28.01 27.98
Support 1 (S1) 27.64 27.68 27.81 27.69 27.22
Support 2 (S2) 27.18 27.49 27.21 27.16
Support 3 (S3) 26.84 27.18 27.09
Support 4 (S4) 26.89